22-hydroxycholesterol has been researched along with Addison Disease and Cerebral Sclerosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andreoletti, P; Berger, J; Cherkaoui-Malki, M; Dias, AM; Geillon, F; Genin, EC; Gondcaille, C; Kase, ET; Lizard, G; Lopez, TE; Nury, T; Savary, S; Trompier, D; Weinhofer, I | 1 |
| Gondcaille, C; Lizard, G; Savary, S; Trompier, D | 1 |
1 review(s) available for 22-hydroxycholesterol and Addison Disease and Cerebral Sclerosis
| Article | Year |
|---|---|
Regulation of the adrenoleukodystrophy-related gene (ABCD2): focus on oxysterols and LXR antagonists.
Topics: Adrenoleukodystrophy; ATP Binding Cassette Transporter, Subfamily D; ATP-Binding Cassette Transporters; Gene Expression Regulation; Humans; Hydroxycholesterols; Liver X Receptors; Molecular Targeted Therapy; Orphan Nuclear Receptors | 2014 |
1 other study(ies) available for 22-hydroxycholesterol and Addison Disease and Cerebral Sclerosis
| Article | Year |
|---|---|
LXR antagonists induce ABCD2 expression.
Topics: Adrenoleukodystrophy; ATP Binding Cassette Transporter, Subfamily D; ATP-Binding Cassette Transporters; Fatty Acids; Gene Expression Regulation; Hep G2 Cells; Humans; Hydroxycholesterols; Liver X Receptors; Orphan Nuclear Receptors; Oxidative Stress | 2014 |